Perceptive Advisors LLC Ocular Therapeutix, Inc Transaction History

Perceptive Advisors LLC

  • $2.28 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$5.93 - $9.08 $964,929 - $1.48 Million
-162,720 Reduced 15.09%
915,775 $6.71 Million
Q4 2024

Feb 14, 2025
SELL
$8.33 - $11.47 $18.7 Million - $25.8 Million
-2,245,973 Reduced 67.56%
1,078,495 $9.21 Million
Q1 2024

May 15, 2024
BUY
$3.85 - $10.93 $12.8 Million - $36.3 Million
3,324,468 New
3,324,468 $30.3 Million

Others Institutions Holding OCUL

# of Institutions
202
Shares Held
137M
Call Options Held
743K
Put Options Held
321K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $961M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email